1.2 Phases of Wound Healing & Cellular Events

Phases of Wound Healing & Cellular Events

Wound healing is a complex, dynamic biological cascade regulated by precise cellular interactions, growth factors, cytokines, and extracellular matrix (ECM) remodeling. Following full-thickness tissue breach, healing progresses through four continuous, overlapping phases: Hemostasis, Inflammation, Proliferation, and Remodeling/Maturation. A disruption or prolongation within any phase prevents progression to full closure and leads to chronic wound formation.

---

Phase 1: Hemostasis (Immediate to Minutes/Hours)

Hemostasis initiates immediately upon vascular disruption, serving two vital objectives: halting hemorrhage and establishing a temporary bio-matrix scaffold for incoming repair cells.

Cellular Events & Biochemical Pathways

1. Vascular Constriction: Microvascular smooth muscle contracts reflexively for 5 to 10 minutes, mediated by neural reflexes and local release of vasoconstrictors including thromboxane A2 and endothelin.
2. Platelet Adhesion & Aggregation: Damaged subendothelial collagen exposes binding sites for circulating platelets. Platelets adhere via von Willebrand factor (vWF) and undergo activation, changing shape and degranulating.
3. Fibrin Clot Formation: Activated platelets release alpha-granules containing key growth factors:
   • Platelet-Derived Growth Factor (PDGF): Chemotactic for neutrophils, macrophages, and fibroblasts.
   • Transforming Growth Factor-Beta (TGF-β): Stimulates collagen synthesis and fibroblast recruitment.
   • Epidermal Growth Factor (EGF) and Fibroblast Growth Factor (FGF). The intrinsic and extrinsic coagulation cascades merge into the common pathway, converting soluble fibrinogen into insoluble fibrin polymer strands. This fibrin-fibronectin mesh traps erythrocytes and platelets, establishing a provisional matrix that secures hemostasis and provides an entryway for immune cells.

---

Phase 2: Inflammation (Days 1 to 4)

The inflammatory phase establishes biological wound bed decontamination, clearing pathogens, devitalized matrix, and foreign debris.

Sequential Cellular Infiltration

Injury --> Vascular Vasodilation --> PMN Influx (24-48 hrs) --> Monocyte Influx / Macrophage Shift (48-72 hrs)

• Vasodilation & Permeability: Following transient vasoconstriction, histamine, bradykinin, and prostaglandins cause microvascular vasodilation and increased endothelial permeability, producing classic inflammatory cardinal signs: redness (rubor), heat (calor), swelling (tumor), and pain (dolor).
• Polymorphonuclear Neutrophils (PMNs): Arriving within 24 to 48 hours, PMNs represent the primary responders. Recruited via chemotaxis (guided by IL-1, TNF-α, bacterial lipopolysaccharides, and fibrin split products), PMNs release Reactive Oxygen Species (ROS) (superoxide radicals) and proteolytic enzymes—specifically Matrix Metalloproteinases (MMP-8/collagenase) and elastase—to kill bacteria and degrade devitalized tissue. Once their endocytic capacity is reached, PMNs undergo apoptosis and are cleared by macrophages.
• Macrophages (The Master Orchestrators): Monocytes migrate from dermal capillaries around 48 to 72 hours, differentiating into tissue macrophages. Macrophages are essential for wound progression; their depletion completely arrests healing. They perform dual critical roles:
  1. Phagocytosis: Ingesting apoptotic PMNs, cellular debris, and bacteria.
  2. Phenotypic Phenotype Transition: Transitioning from pro-inflammatory (M1 phenotype) to repair-promoting (M2 phenotype). M2 macrophages secrete essential growth factors required for proliferation:
     • PDGF and TGF-β (recruiting fibroblasts).
     • Vascular Endothelial Growth Factor (VEGF) (initiating angiogenesis).
     • Basic Fibroblast Growth Factor (bFGF).

---

Phase 3: Proliferation (Days 4 to 21)

The proliferative phase focuses on structural reconstruction: constructing new connective tissue, developing a dense vascular bed, pulling wound margins together, and re-establishing epidermal integrity.

Deep-Dive: Collagen Synthesis & Angiogenesis

Fibroblasts utilize ascorbic acid (Vitamin C), iron, and alpha-ketoglutarate as essential cofactors to hydroxylate proline and lysine residues during procollagen synthesis. Un-hydroxylated collagen cannot form stable triple helices and undergoes rapid degradation. Initial structural support relies on Collagen Type III, a thin, pliable, immature collagen network.

Concurrently, hypoxia (low tissue oxygen tension, $PO_2 < 30\text{ mmHg}$) within the wound center triggers Hypoxia-Inducible Factor 1-alpha (HIF-1α), driving local VEGF secretion. Endothelial cells sprout new capillary loops into the wound bed, creating moist, firm, granular, bright red granulation tissue.

Epithelialization proceeds as keratinocytes at the wound margins lose desmosomal attachments, flatten, and migrate across the viable moist wound surface. If dry eschar is present, keratinocytes must secrete MMPs to dissect underneath the necrotic crust, significantly delaying closure.

---

Phase 4: Remodeling & Maturation (Day 21 to 1–2 Years)

The final phase emphasizes structural rearrangement and strengthening of newly formed collagenous matrix.

[ Immature Matrix: Collagen III ] --(MMP Breakdown / TIMP Regulation)--> [ Mature Matrix: Collagen I ]
  - Randomly oriented fibers                                              - Parallel fibers aligned along stress lines
  - Low tensile strength                                                   - Maximum tensile strength: UP TO 80%

Collagen Re-organization and Tensile Strength Recovery

• Collagen Transition: Over months, immature Collagen Type III is systematically degraded by matrix metalloproteinases (MMPs) and replaced by Collagen Type I, the predominant structural collagen of normal reticular dermis. Tissue Inhibitors of Metalloproteinases (TIMPs) regulate MMP activity to prevent excessive matrix breakdown.
• Fiber Realignment: Collagen Type I fibers re-orient along local mechanical lines of stress, forming cross-linked covalent bonds that dramatically increase tissue strength.
• Vascular Regression: Capillaries regress and cellularity decreases, transforming bright red granulation tissue into a pale, avascular, fibrous scar.
• Tensile Strength Benchmarks: Scar tissue gains strength slowly:
  • End of Week 1: ~3% of unwounded skin strength.
  • End of Week 3 (Transition to Remodeling): ~20% of unwounded skin strength.
  • End of Month 3 to 1 Year: Reaches a maximum of 80% of original unwounded skin tensile strength.

Critical Clinical Rule: Healed wound tissue NEVER regains 100% of original skin tensile strength. Sites of previous tissue breakdown remain permanently susceptible to recurrent breakdown when exposed to pressure, friction, or shear forces.

Systemic Factors Impairing Cellular Phases

Multiple host factors impair cellular performance across healing phases:

• Protein Malnutrition: Deficiencies in serum albumin (< 3.5 g/dL) and prealbumin (< 15 mg/dL) limit amino acid availability for fibroblast collagen synthesis.
• Hypoxia and Tissue Perfusion: Transcutaneous oxygen pressure ($TcPO_2 < 30\text{ mmHg}$) halts oxidative killing by neutrophils and stops collagen hydroxylation.
• Hyperglycemia ($HbA1c > 7.0%$): Causes neutrophil dysfunction, blunted phagocytosis, formation of Advanced Glycation End-products (AGEs), and microvascular damage.
• Exogenous Corticosteroids: Inhibit macrophage activation, block TGF-β secretion, and suppress fibroblast collagen synthesis (vitamin A therapy can partially reverse steroid-induced healing inhibition).